{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:44:11Z","timestamp":1791888251933,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.bbapap.2009.07.027","type":"journal-article","created":{"date-parts":[[2009,8,12]],"date-time":"2009-08-12T06:04:03Z","timestamp":1250057043000},"page":"404-409","source":"Crossref","is-referenced-by-count":174,"title":["Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target"],"prefix":"10.1016","volume":"1804","author":[{"given":"Giuseppina","family":"De Simone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbapap.2009.07.027_bib1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbapap.2009.07.027_bib2","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/0042-6822(92)90464-Z","article-title":"A novel quasi-viral agent, MaTu, is a two-component system","volume":"187","author":"Pastorekova","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.bbapap.2009.07.027_bib3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/ijc.2910540218","article-title":"Expression of MaTu-MN protein in human tumor cultures and in clinical specimens","volume":"54","author":"Zavada","year":"1993","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbapap.2009.07.027_bib4","first-page":"2877","article-title":"Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and putative helix-loop-helix DNA binding segment","volume":"9","author":"Pastorek","year":"1994","journal-title":"Oncogene"},{"key":"10.1016\/j.bbapap.2009.07.027_bib5","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1006\/geno.1996.0223","article-title":"Human MN\/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships","volume":"33","author":"Opavsky","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.bbapap.2009.07.027_bib6","series-title":"Carbonic anhydrase: its inhibitors and activators","first-page":"255","article-title":"Cancer-related carbonic anhydrase isozymes and their inhibition","author":"Pastorekov\u00e1","year":"2004"},{"key":"10.1016\/j.bbapap.2009.07.027_bib7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bbapap.2009.07.027_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/sj.bjc.6600936","article-title":"Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer","volume":"89","author":"Potter","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbapap.2009.07.027_bib9","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nature04871","article-title":"Hypoxia signalling in cancer and approaches to enforce tumour regression","volume":"441","author":"Pouyssegur","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbapap.2009.07.027_bib10","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1006\/bbrc.2001.5824","article-title":"The catalytic properties of human carbonic anhydrase IX","volume":"288","author":"Wingo","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbapap.2009.07.027_bib11","doi-asserted-by":"crossref","first-page":"27799","DOI":"10.1074\/jbc.M800938200","article-title":"Biochemical characterization of CA IX, one of the most active carbonic anhydrase isozymes","volume":"283","author":"Hilvo","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2009.07.027_bib12","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0960-894X(03)00091-X","article-title":"Carbonic anhydrase inhibitors. Inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides","volume":"13","author":"Vullo","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbapap.2009.07.027_bib13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/1475636031000138732","article-title":"Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, cancer-associated isozyme IX with anions","volume":"18","author":"Vullo","year":"2003","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.bbapap.2009.07.027_bib14","unstructured":"V. Alterio, M. Hilvo, A. Di Fiore, C.T. Supuran, P. Pan, S. Parkkila, A. Scaloni, J. Pastorek, S. Pastorekova, S.M. Monti, A. Scozzafava, G. De Simone, Crystal structure of the extracellular catalytic domain of the tumor-associated human carbonic anhydrase IX. Proc. Natl. Acad. Sci. USA (in press)."},{"key":"10.1016\/j.bbapap.2009.07.027_bib15","doi-asserted-by":"crossref","first-page":"13512","DOI":"10.1074\/jbc.272.21.13512","article-title":"Catalytic properties of murine carbonic anhydrase IV","volume":"272","author":"Hurt","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2009.07.027_bib16","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.bmcl.2008.01.077","article-title":"Carbonic anhydrase inhibitors. Interactions of phenols with the 12 catalytically active mammalian isoforms (CA I\u2013XIV)","volume":"18","author":"Innocenti","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbapap.2009.07.027_bib17","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1021\/ja809683v","article-title":"Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors","volume":"131","author":"Maresca","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbapap.2009.07.027_bib18","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.bmcl.2003.12.029","article-title":"Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX","volume":"14","author":"Pastorekova","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbapap.2009.07.027_bib19","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1021\/jm031079w","article-title":"Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX","volume":"47","author":"Casey","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbapap.2009.07.027_bib20","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.bmcl.2004.11.058","article-title":"Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic\/tumor-associated carbonic anhydrase isozymes I, II and IX with bis-sulfamates","volume":"15","author":"Winum","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbapap.2009.07.027_bib21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.radonc.2009.06.019","article-title":"Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumour model","volume":"92","author":"Dubois","year":"2009","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.bbapap.2009.07.027_bib22","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1021\/jm0501073","article-title":"Carbonic anhydrase inhibitors. Sulfonamides inhibit isozyme IX mediated acidification of hypoxic tumors. Fluorescent sulfonamides design as probes of membrane-bound carbonic anhydrase isozymes involvement in tumorigenesis","volume":"48","author":"Cecchi","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbapap.2009.07.027_bib23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.febslet.2004.10.043","article-title":"Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH","volume":"577","author":"\u0160vastov\u00e1","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbapap.2009.07.027_bib24","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.1021\/jm060967z","article-title":"A novel class of carbonic anhydrase inhibitors: glycoconjugate benzene sulfonamides prepared by \u201cclick-tailing\u201d","volume":"49","author":"Wilkinson","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbapap.2009.07.027_bib25","doi-asserted-by":"crossref","first-page":"20473","DOI":"10.1074\/jbc.M801330200","article-title":"Tumor-associated carbonic anhydrase 9 spatially coordinates intracellular pH in three-dimensional multicellular growths","volume":"283","author":"Swietach","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2009.07.027_bib26","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1158\/0008-5472.CAN-08-2470","article-title":"Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH","volume":"69","author":"Chiche","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbapap.2009.07.027_bib27","doi-asserted-by":"crossref","unstructured":"J.K.J. Ahlskog, C.E. Dumelin, S. Tr\u00fcssel, J. Marlind, D. Neri, In vivo targeting of tumor-associated carbonic anhydrases using acetazolamide derivatives, Bioorg. Med. Chem. Lett. 19 (2009) 4851\u20134856, doi:10.1016\/j.bmcl.2009.06.022.","DOI":"10.1016\/j.bmcl.2009.06.022"},{"key":"10.1016\/j.bbapap.2009.07.027_bib28","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.radonc.2007.04.018","article-title":"Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors","volume":"83","author":"Dubois","year":"2007","journal-title":"Radiother. Oncol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963909001952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963909001952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T15:56:40Z","timestamp":1545062200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570963909001952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S1570963909001952"],"URL":"https:\/\/doi.org\/10.1016\/j.bbapap.2009.07.027","relation":{},"ISSN":["1570-9639"],"issn-type":[{"value":"1570-9639","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}